Work

Phase II study of rituximab and cladribine (2-CDA) in newly diagnosed mantle cell lymphoma (MCL) (N0189)

Year: 2006

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.24.18_suppl.17505

Authors: D. J. Inwards, D. W. Hillman, P. A. Fishkin, W. L. White, R. F. Morton, S. R. Dakhil, D. A. Nikcevich, D. B. Wender, T. R. Fitch, P. J. Kurtin

Institutions: Mayo Clinic, June E. Nylen Cancer Center, Duluth Clinic

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2604049200

Cites:

Cited by: 2

Related to: 10